The vaccine, Nexvan2, is being tested worldwide. The first test was in 2011 and found the vaccine to be safe. In 2017, $40 million in funding was received by the company developing the vaccine, ImmusanT. The funding will allow additional research, including a second round of testing that is set to include 150 patients from the United States, Australia, and New Zealand.
“Through this study we anticipate making new insights that will further our ability to demonstrate specific suppression of the immune response to gluten epitopes and associated effects of celiac disease,” Dr. Ken Truitt, ImmusanT chief medical officer, told BeyondCeliac.org.
Follow the progress of this life-changing vaccine here.
Under the Nile Swaddle Blanket$47.00
Under the Nile Elephant Lovey$22.00
Under the Nile Solid Skull Hat
12% OFF Under the Nile Side Snap Kimono - White Stork$36.00 $40.80
12% OFF Under the Nile Convertible Romper - White Stork$36.00 $40.80
Babybear Shop Cheeky Baby Butter Organic Baby Balm$34.00
- Organic Baby